SCREENING TOSSICOLOGICO RAPIDO – Codice SC9000U

Total Page:16

File Type:pdf, Size:1020Kb

SCREENING TOSSICOLOGICO RAPIDO – Codice SC9000U SCREENING TOSSICOLOGICO RAPIDO – Codice SC9000U Il kit per l’analisi tossicologico-forense è un metodo di screening per analizzare centinaia di composti in modalità positiva e negativa nelle urine. E’ possibile determinare le seguenti molecole: MODALITA’ POSITIVA: Amitrole Altretamine Baclofen 17 -alpha -Methyltestosterone Alypin Bambuterol 2-Amino -5-chlorobenzophenone Amantadine Bamifylline 2-Amino -5-nitrobenzophenone Ambroxol Bamipin 2-Hydroxyethylflurazepam Ambucetamide Beclamide 3,4 -Methylenedioxyamphetamine Amezinium Beclometasone dipropionate 3,4 -Methylenedioxyethylamphetamine Amidopyrin Befunolol 3,4 -Methylenedioxymethamphetamine Amidotrizoic Acid Bendiocarb 3,5 -Diiodotyrosin e Amiloride Benfluorex 4-Benzamidosalicyclic acid Aminodantrolene Benodanil 6-Mercaptourine Aminoglutethimide Benperidole 6-O-Monoacetylmorphine Aminophenazone Benproperine 7-Aminoclonazepam Aminopromazine Bensultap 7-Aminodesmethylflunitrazepam Aminorex Bentiromide 7-Aminoflunitrazepam Amiodarone Benzatropine 7-Aminonitrazepam Amiphenazole Benzocaine 9-Hydroxyrisperidone Amisulpride Benzoctamine cebutolol Amitriptylin Benzododecinium Aceclidine Amlodipine Benzoylecgonine Aceclofenac Ammoidin Benzthiazuron Acemetacin Amorolfine Berberine Acepromazine Amoxicillin Betamethasone 21 -phosphate Acepromet azine Amphetamine Betaxolol Acetiamin Amrinone Bevonium Acetylaminonitroprophoxybenzene Antazoline Bezafibrate Aciclovir Apalcillin Biperiden Actinoquinol Apomorphine Bisoprolol Adenine Apophedrin Bornaprine Adrenalone Apraclonidin Brodifacoum Ajmaline Aprinidine Bromacil Alachlor Atenolol Bromazepam Alclometasone -17,21 -dipropionate Atorvastatin Bromocriptine Alimemazine Atraton Brompheniramine Alizapride Atrazine -desethyl Brotizolam Allopurinol Atropine Bucetin Almitrine Atropinmethylbromid Bufexamac alpha -Hydroxyalprazolam Azatadine Bumetanide alpha -Hydroxytriazolam Azelastine Bunaz osin Alprazo lam Azi ntamid Bunitrolol Alprenolol Aztreonam Bupivacaine 1 Bupranolol Clemastine Dibutyl adipate Buprenorphine Clenbuterol Diclofenac Buprofezin Clobazam Dicycloverine Buspirone Clobenzepam Dienogest Butaperazine Clobutinol Diethazine Butetamate Clomethiazole Diethylcarbamazine Butoxycaine Clomip ramine Difenoconazole Cafaminol Clonazepam Difenoxuron Caffeine Clonidine Diflucortolone Candesartan Clopenthixol Dihydrocodeine Caproylresorcinol Clopidogrel Dihydroergocristin Captopril Cloprednol Dihydroergotamine Carazolol Clozapine Dilaze p Carbamazepine Cocaine Diltiazem Carbamazepine 10,11 -epoxide Codeine Dimetindene Carbendazim Coniine Dimetotiazine Carb inoxamine Corticosterone Dimetridazole Carbutamide Cortisone Dioxethedrin Carbuterol Cotinine Diphenamid Carteolol Coumatetralyl Diphenhydramine Carvedilol Croconazole Diponium Celiprolol Cromoglicic acid Diprophylline Cerivastatin Cyamemazine Dipyridamole Cetirizine Cyclicine Disopyramide Chinine Cyclophosphamide Dixyrazine Chlorazanil Cyclovalone Dobutamine Chlorbenzoxamine Cyprohepta dine Dorzolamide Chlorcyclizine Cytarabine Doxapram Chlordiazepoxide D3 -Doxepin Doxepin Chloridazon D5 -Diazepam Doxylamine Chlormadinone Acetate Dapiprazole Drofenine Chlormequat Deflazacort Dummy Chlorphenethiazine Demeton -S-methylsulfone Ecgoninemethylest er Chlorpheniramine Denaverine EDDP Chlorpromazine Desalkylflurazepam Embutramide Chlorpromazine Sulfoxide Desipramine Enalapril Chlorprothixene Desmedipham Enoximone Cilastatin Desmethylclobazam Ephedrine Cilazapril Desmethylclomipramine Eprosartan Cimetidine Dexamethasone Esculin Cinnarizine Dexamethasone 21 -isonicotinate Esmolol Cinoxacin Dexfenfluramine Estazolam Ciprofloxacin Dextromethorphan Ethenzamide Cisapride Dextropropoxyphene Etofenamate Citalopram Diaveridine Etomidate Clarithromycin Diazepam Etoposide 2 Famotidine Guanabenz Levomepromazine Fedrilate Guanethidine Levopropylhexedrin Felbamate Guanfacine Lidocaine Felodipine Guanoxan Lisinopril Fenarimol Haloperidol Lonazolac Fendiline Haloxyfop ethoxyethyl ester Loperamide Fenetylline Heptaminol Loratadine Fenfluramine Heroin Lorazepam Fenpipramide Hexazinone Lormetazepam Fe npiprane Hexobendine Losartan Fenproporex Histamine Loxapine Fentanyl Histapyrrodine Lysergide Fenticonazole Homatropine Mafenide Fexofenadine Hordenine Maprotiline Flecainide Hydrocodone MBDB Flocoumafen Hydrocortisone Mebeverine Floctafenine Hydrocortisone 21 -acetate Meclizine Fluanisone Hydromorphone Meclofenamic acid Fluconazole Hydroxyzine Mecloxamine Flumazenil Hymecromon e Meclozine Flunarizine Imipramine Medazepam Flunitrazepam Indanazoline Mefenamic acid Fluoxetine Indapamine Mefenorex Flupentixol Indinavir Mefexamide Fluphenazine Indoprofen Mefloquine Flupirtine Indoramin Melatonin Flurazepam Iopodic acid Melitracen Flurochloridone Ipratropium Meloxicam Fluspirile n Iprazochrome Melperone Fluticasone Propionate Irbesartan Melphalan Fluvastadine Isoaminile Mepindolol Fluvoxamine Isoconazole Mepivacaine Fuberidazole Isoprenaline Meptazinol Furalaxyl Isoproturon Mequitazine Gabapentin Isothipendyl Mescaline Galantamine Isoxicam Mesoridazine Gallopamil Isoxsuprine Mesuxim ide Gemcitabine Kavain Metaclazepam Glibenclamide Ketamine Metamfepramone Glibornuride Ketoprofen Metamitron Gliclazide Ketorolac Metamphetamine Glimepiride Ketotifen Metazachlor Glipizide Lamotrigine Metenolone acetate Gliquidone Lercanidipine Metformin Griseofulvin Levocabastine Methabenzthiazuron Guaifenesin Levodopa Methadone 3 Methaphenilene Nandrolon e Oxeladin Methapyrilene Naphazoline Oxetacaine Methaqualon N-Despropylpropafenone Oxiconazole Methazolamide Nebivolol Oxilofrine Methfuroxam Nefopam Oxitriptan Methocarbamol Nicardipine Oxitropium Methoprotryne Nicotinamide Oxomemazine Methotrexate Nicotine Oxprenolol Me thylephedrine Nifedipine Oxybuprocaine Methylphenidate Nifenazone Oxybutynin Methylscopolamine Niflumic acid Oxycodone Methylthiouracil Nimodipine Oxyfedrine Metipranolol Nimorazole Oxymet azoline Metixene Nisoldipine Oxymorphon Metoprolol N-Isopropylsalicylamide Oxypertine Metronidazole Nitrazepam Papaverine Metsulfuron -methyl Nitrendipine Paracetamol Metyrapone Nizatidine Paraoxon Mexiletine N-Methylephedrine Paroxetine Mianserin Nomifensine Penfluridol Miconazole Norbuprenorphine Pentamidine Midazolam Nordiazepam Pentoxyverine Midodrine Nordiazepam N -ethyl Perazine Milrinone Norephedrine Periciazine Minoxidil Norethisterone Perindopril Mirtazapine Norethisterone acetate Perphenazine Mizolastine Norfenefrine Pethidine Moclobemide Norfentanyl Phenacetin Modafinil Norfloxacin Phenazone Molsidomine Normorphine Phenazopyridine Monocrotophos Nortriptyline Phencyclidine Monolinuron Noscapine Phenelzine Moperone Nuarimol Phenira mine Morphine Obidoxime Phenprocoumon Morphine -3-ß-D-glucuronide Ofloxacin Phenylephrine Moxaverine Olanzapine Phenyltoloxamine Moxisylyte Ondansetron Phenytoin Moxonidine Op ipramol Pholedrine Nabumetone Orciprenaline Physostigmine Nadolol Ornidazole Pilocarpine Naftidrofuryl Orphenadrine Pindolol Naftifine Oxadixyl Pioglitazone Nalidixic acid Oxamyl Pipamperone Nalorphine Oxatomide Pirbuterol Naloxone Oxazepam Pirenzepine Naltrexone Oxcarbazepine Piretanide 4 Piritramide Reproterol Tertalolol Piroxicam Reserpine Tetracaine Pizotifen Riluzole Tetrazepam Practolol Risperidone Tetroxoprim Prajmalium Ritodrine Tetryzoline Pramipexole Rizatriptan THC Prazep am Ropinirole THC -COOH Prazosin Ropivacaine THC -OH Prednisolone Rosiglitazon Thebacon Prednisone Salbutamol Theobromine Prilocaine Salicylamide Theophylline Primaquine Scopolamine Thiabendazole Primidone Serotonin Thiamazole Procainamide Sertindole Thiamine Prochlorperazine Sertraline Thiopropazate Procyclidine Sildenafil Thioproperazine Progesterone Simazine Thioridazine Promazine Sotalol Thiram Promethazin Spirapril Tiagabine Prometryn Stanozolol Tiapride Propafenone Sulfabenzamide Ticlopidine Propiconazole Sulfadiazine Tiemonium Propionylpromazine Sulfadoxine Tilidine Propipocaine Sulfaethidole Timolol Propiverine Sulfaguanidine Tinidazole Propranolol Sulfamethizole Tizanidine Propyphenazone Sulfamethoxazole Tocainide Prothiopendyl Sulfapyridine Tolazoline Protriptyline Sulfaquinoxaline Tolbutamide Pseudoephedrine Sulindac Toliprolol Psilocin Sulpiride Tolnaftate Pyranocoumarin Sultiame Tolpropamine Pyribenzamine Sumatriptan Tolycaine Pyridoxine Suxibuzone Topotecan Pyrimethamine Tadalafil Torasemide Pyritinol Talinolol Tramadol Pyrvinium Tamoxifen Tranexamic acid Quetiapine Telmisartan Trazodone Quinapril Temazepam Triadimenol Quinine Tenocixam Triallate Ramipril Terazosi ne Triamterene Ranitidine Terbinafine Triazolam Raubasine Terbutaline Trifluperazine Reboxetine Terbutryn Trifluperidol Remoxipride Terconazole Triflupromazine Repaglinide Terfenadine Trimethobenzamide 5 Trimethoprim Tulobuterol Xantinol Trimipramine Urapi dil Xipamide Tripelennamine Valdecoxib Xylometazoline Triprolidine Valsartan Yohimbine Tritoqualine Vardenafil Zolpidem Tromantadine Venlafaxine Zopiclone Tropisetron Verapamil Zuclopenthixol Trospium Vincamine Tryptamine Warfarin MODALITA’ NEGATIVA: Azelaic Acid Ethyl sulfate 2-Amino -5-nitrobenzophenone Aztreonam Ethyl sulfate -D5 4-Benzamidosalicycl ic acid Benserazid Furosemid 5-(p -Methylphenyl) -phenylhydantoin Benzthiazide Hydrochlorothiazide 5-Aminosalicylic acid Bezafibrate Morphin -3ßD -glucuronide -D3 6-Mercaptourine Brallobarbital Pentobarbital Acetazolamide Carbenoxolone Phenobarbital Acetylsalicylic Acid Chlor othiazide Propallylonal Adenine Cimetidine THC -COOH Adenosine Cinchonine THC -OH Adrenalone Cortisone Triamcinolone Alpros tadil Dinoprost Amobarbital Epinephrine Amoxicillin Ethyl glucuronide Atorvastatin
Recommended publications
  • PHARMACEUTICAL APPENDIX to the TARIFF SCHEDULE 2 Table 1
    Harmonized Tariff Schedule of the United States (2020) Revision 19 Annotated for Statistical Reporting Purposes PHARMACEUTICAL APPENDIX TO THE HARMONIZED TARIFF SCHEDULE Harmonized Tariff Schedule of the United States (2020) Revision 19 Annotated for Statistical Reporting Purposes PHARMACEUTICAL APPENDIX TO THE TARIFF SCHEDULE 2 Table 1. This table enumerates products described by International Non-proprietary Names INN which shall be entered free of duty under general note 13 to the tariff schedule. The Chemical Abstracts Service CAS registry numbers also set forth in this table are included to assist in the identification of the products concerned. For purposes of the tariff schedule, any references to a product enumerated in this table includes such product by whatever name known.
    [Show full text]
  • Partial Agreement in the Social and Public Health Field
    COUNCIL OF EUROPE COMMITTEE OF MINISTERS (PARTIAL AGREEMENT IN THE SOCIAL AND PUBLIC HEALTH FIELD) RESOLUTION AP (88) 2 ON THE CLASSIFICATION OF MEDICINES WHICH ARE OBTAINABLE ONLY ON MEDICAL PRESCRIPTION (Adopted by the Committee of Ministers on 22 September 1988 at the 419th meeting of the Ministers' Deputies, and superseding Resolution AP (82) 2) AND APPENDIX I Alphabetical list of medicines adopted by the Public Health Committee (Partial Agreement) updated to 1 July 1988 APPENDIX II Pharmaco-therapeutic classification of medicines appearing in the alphabetical list in Appendix I updated to 1 July 1988 RESOLUTION AP (88) 2 ON THE CLASSIFICATION OF MEDICINES WHICH ARE OBTAINABLE ONLY ON MEDICAL PRESCRIPTION (superseding Resolution AP (82) 2) (Adopted by the Committee of Ministers on 22 September 1988 at the 419th meeting of the Ministers' Deputies) The Representatives on the Committee of Ministers of Belgium, France, the Federal Republic of Germany, Italy, Luxembourg, the Netherlands and the United Kingdom of Great Britain and Northern Ireland, these states being parties to the Partial Agreement in the social and public health field, and the Representatives of Austria, Denmark, Ireland, Spain and Switzerland, states which have participated in the public health activities carried out within the above-mentioned Partial Agreement since 1 October 1974, 2 April 1968, 23 September 1969, 21 April 1988 and 5 May 1964, respectively, Considering that the aim of the Council of Europe is to achieve greater unity between its members and that this
    [Show full text]
  • (12) Patent Application Publication (10) Pub. No.: US 2005/0112135 A1 Cormier Et Al
    US 2005O112135A1 (19) United States (12) Patent Application Publication (10) Pub. No.: US 2005/0112135 A1 Cormier et al. (43) Pub. Date: May 26, 2005 (54) ULTRASOUND ASSISTED TRANSIDERMAL Publication Classification WACCINE DELIVERY METHOD AND SYSTEM (51) Int. Cl." .......................... A61K 39/12; A61M 31/00 (52) U.S. Cl. ......................................... 424/185.1; 604/500 (76) Inventors: Michel J.N. Cormier, Mountain View, CA (US); WeiOi Lin, Palo Alto, CA (US); Georg Widera, Palo Alto, CA (57) ABSTRACT (US) An apparatus and method for transdermally delivering a vaccine comprising a delivery System having (i) a micro Correspondence Address: projection member (or System) that includes a plurality of Francis Law Group microprojections (or array thereof) that are adapted to pierce 1942 Embarcadero through the Stratum corneum into the underlying epidermis Oakland, CA 94.606 (US) layer, or epidermis and dermis layers and (ii) an ultrasonic device. In one embodiment, the vaccine is contained in a (21) Appl. No.: 10/971,338 biocompatible coating that is applied to the microprojection Filed: Oct. 21, 2004 member. In a further embodiment, the delivery system (22) includes a gel pack having a vaccine-containing hydrogel Related U.S. Application Data formulation that is disposed on the microprojection member after application to the skin of a patient. In an alternative (60) Provisional application No. 60/524,062, filed on Nov. embodiment, the vaccine is contained in both the coating 21, 2003. and the hydrogel formulation. Patent Application
    [Show full text]
  • Federal Register / Vol. 60, No. 80 / Wednesday, April 26, 1995 / Notices DIX to the HTSUS—Continued
    20558 Federal Register / Vol. 60, No. 80 / Wednesday, April 26, 1995 / Notices DEPARMENT OF THE TREASURY Services, U.S. Customs Service, 1301 TABLE 1.ÐPHARMACEUTICAL APPEN- Constitution Avenue NW, Washington, DIX TO THE HTSUSÐContinued Customs Service D.C. 20229 at (202) 927±1060. CAS No. Pharmaceutical [T.D. 95±33] Dated: April 14, 1995. 52±78±8 ..................... NORETHANDROLONE. A. W. Tennant, 52±86±8 ..................... HALOPERIDOL. Pharmaceutical Tables 1 and 3 of the Director, Office of Laboratories and Scientific 52±88±0 ..................... ATROPINE METHONITRATE. HTSUS 52±90±4 ..................... CYSTEINE. Services. 53±03±2 ..................... PREDNISONE. 53±06±5 ..................... CORTISONE. AGENCY: Customs Service, Department TABLE 1.ÐPHARMACEUTICAL 53±10±1 ..................... HYDROXYDIONE SODIUM SUCCI- of the Treasury. NATE. APPENDIX TO THE HTSUS 53±16±7 ..................... ESTRONE. ACTION: Listing of the products found in 53±18±9 ..................... BIETASERPINE. Table 1 and Table 3 of the CAS No. Pharmaceutical 53±19±0 ..................... MITOTANE. 53±31±6 ..................... MEDIBAZINE. Pharmaceutical Appendix to the N/A ............................. ACTAGARDIN. 53±33±8 ..................... PARAMETHASONE. Harmonized Tariff Schedule of the N/A ............................. ARDACIN. 53±34±9 ..................... FLUPREDNISOLONE. N/A ............................. BICIROMAB. 53±39±4 ..................... OXANDROLONE. United States of America in Chemical N/A ............................. CELUCLORAL. 53±43±0
    [Show full text]
  • PHARMACEUTICAL APPENDIX to the HARMONIZED TARIFF SCHEDULE Harmonized Tariff Schedule of the United States (2008) (Rev
    Harmonized Tariff Schedule of the United States (2008) (Rev. 2) Annotated for Statistical Reporting Purposes PHARMACEUTICAL APPENDIX TO THE HARMONIZED TARIFF SCHEDULE Harmonized Tariff Schedule of the United States (2008) (Rev. 2) Annotated for Statistical Reporting Purposes PHARMACEUTICAL APPENDIX TO THE TARIFF SCHEDULE 2 Table 1. This table enumerates products described by International Non-proprietary Names (INN) which shall be entered free of duty under general note 13 to the tariff schedule. The Chemical Abstracts Service (CAS) registry numbers also set forth in this table are included to assist in the identification of the products concerned. For purposes of the tariff schedule, any references to a product enumerated in this table includes such product by whatever name known. ABACAVIR 136470-78-5 ACIDUM GADOCOLETICUM 280776-87-6 ABAFUNGIN 129639-79-8 ACIDUM LIDADRONICUM 63132-38-7 ABAMECTIN 65195-55-3 ACIDUM SALCAPROZICUM 183990-46-7 ABANOQUIL 90402-40-7 ACIDUM SALCLOBUZICUM 387825-03-8 ABAPERIDONUM 183849-43-6 ACIFRAN 72420-38-3 ABARELIX 183552-38-7 ACIPIMOX 51037-30-0 ABATACEPTUM 332348-12-6 ACITAZANOLAST 114607-46-4 ABCIXIMAB 143653-53-6 ACITEMATE 101197-99-3 ABECARNIL 111841-85-1 ACITRETIN 55079-83-9 ABETIMUSUM 167362-48-3 ACIVICIN 42228-92-2 ABIRATERONE 154229-19-3 ACLANTATE 39633-62-0 ABITESARTAN 137882-98-5 ACLARUBICIN 57576-44-0 ABLUKAST 96566-25-5 ACLATONIUM NAPADISILATE 55077-30-0 ABRINEURINUM 178535-93-8 ACODAZOLE 79152-85-5 ABUNIDAZOLE 91017-58-2 ACOLBIFENUM 182167-02-8 ACADESINE 2627-69-2 ACONIAZIDE 13410-86-1 ACAMPROSATE
    [Show full text]
  • 2 12/ 35 74Al
    (12) INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property Organization International Bureau (10) International Publication Number (43) International Publication Date 22 March 2012 (22.03.2012) 2 12/ 35 74 Al (51) International Patent Classification: (81) Designated States (unless otherwise indicated, for every A61K 9/16 (2006.01) A61K 9/51 (2006.01) kind of national protection available): AE, AG, AL, AM, A61K 9/14 (2006.01) AO, AT, AU, AZ, BA, BB, BG, BH, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, (21) International Application Number: DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, PCT/EP201 1/065959 HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, (22) International Filing Date: KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, 14 September 201 1 (14.09.201 1) ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PE, PG, PH, PL, PT, QA, RO, RS, RU, (25) Filing Language: English RW, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, (26) Publication Language: English TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW. (30) Priority Data: 61/382,653 14 September 2010 (14.09.2010) US (84) Designated States (unless otherwise indicated, for every kind of regional protection available): ARIPO (BW, GH, (71) Applicant (for all designated States except US): GM, KE, LR, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, NANOLOGICA AB [SE/SE]; P.O Box 8182, S-104 20 ZM, ZW), Eurasian (AM, AZ, BY, KG, KZ, MD, RU, TJ, Stockholm (SE).
    [Show full text]
  • L IIDIII11H11 IIHI DID IIDI1IIII11 ID1 I Hill1hib IIHI DIII DII DID I1 IIIIIH
    (12) INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property Organization International Bureau l IIDIII11H11IIHI DIDIIDI1IIII11 ID1IHill1HIB IIHI DIII DII DIDI1 IIIIIH I11111IIII (43) International Publication Date (10) International Publication Number 3 November 2005 (03.11.2005) W O 2005/102334 A3 (51) International Patent Classification : A61K 9170 At AU. AZ, HA, BB, HG, BR, BW, BY, HZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EC, FE, EU, ES, HI, (21) International Application Number: GB, GD, GE, OH, GM, HR, HU, ID, IL, IN, IS, J, KU, PCT/US2005/009153 KG, Kg KR, KZ, LC, LK, LR, LS, T LU, LV, MA, MD, (22) International Filing Date: 18 March 2005 (18.03.2005) P, PL, PT, RO, U, D, SE, SO, SK, NL, SM, SG, TJ, TM, T, R, IT, TZ, UA, UG, US, UZ, SC, VN, Y, (25) Filing Language: English T, ZM, TU (26) Publication Language: English (84) Designated States (unless otherwise indicated, fi6r every (30) Priority Data: kind of regional protection available): ARIPO (BW OH, 60/561,949 13 April 2004 (13.04.2004) US GM, KE, LS. MW, MZ, NA, SD. SL, SZ. IL, UG, ZM, LW), Eurasian (AM, AL, BY, KG, KZ, MD, RU, Ti,TM), (71) Applicant (for all designated States except US): ALZA European (AT, BE, BO, CH, CY, CZ, DE, DK, EE, ES, H, CORPORATION [US/US]; 1900 Charleston Road, P.O. ER, GB, OR, ItO, TE, IS, IT, LI, LU, MC, NE, PL, PT, RO, Box 7210, Mountain View, CA 94043 (US). SE, 81,5K,'R), QAPI (HF BJ, CE, CG, CI, CM, GA, ON, (72) Inventors; and GQ, OW, ML, MR, NE, SN, ID, TO).
    [Show full text]
  • (12) United States Patent (10) Patent No.: US 6,638,528 B1 Kanios (45) Date of Patent: Oct
    USOO6638528B1 (12) United States Patent (10) Patent No.: US 6,638,528 B1 Kanios (45) Date of Patent: Oct. 28, 2003 (54) COMPOSITIONS AND METHODS TO FOREIGN PATENT DOCUMENTS EFFECT THE RELEASE PROFILE IN THE TRANSIDERMALADMINISTRATION OF EP O 224 981 6/1987 ACTIVE AGENTS EP O 697 860 4/1994 EP 913 158 6/1999 (75) Inventor: David Kanios, Miami, FL (US) WO WO94/06436 3/1994 (73)73) AssiSignee: : NFpy, Ph armaceuticals,icals, IInc., MiamiMiami, WO WO95/22322WO94/26257 11/19948/1995 ( ) WO WO95/31.188 11/1995 (*) Notice: Subject to any disclaimer, the term of this WO WO96/21433 7/1996 patent is extended or adjusted under 35 WO WO98/17263 4/1998 U.S.C. 154(b) by 0 days. WO WO98/31349 7/1998 WO WO98/39042 9/1998 (21) Appl. No.: 10/086,457 WO WO99/55286 11/1999 WO WOOO/59483 10/2000 (22) Filed: Mar. 1, 2002 WO WOOO/74661 12/2000 Related U.S. Application Data WO PCT/USO1/O1999 8/2001 (63) Continuation of application No. 09/765,932, filed on Jan. 19, OTHER PUBLICATIONS 2001, now abandoned. (60) visional application No. 60/177,103, filed on Jan. 20, Dow Chemical Company, “Product Specification Sheet for 7 Ethocel FP Polymers.”y Oct. 1998, U.S.A. (51) Int. Cl." ........................... A61K 9/70; A61K 13/00 (52) U.S. Cl. ....................... 424/449; 424/448; 424/443; Dow Chemical Company, “Bibliography: ETHOCEL Eth 424/484 ylcellulose in Pharmaceuticals,” Jun. 1996, U.S.A. (58) Field of Search ................................. 424/448, 449, 424/484, 487, 488, 443 (List continued on next page.) (56) References Cited U.S.
    [Show full text]
  • Council of Europe Committee of Ministers (Partial
    COUNCIL OF EUROPE COMMITTEE OF MINISTERS (PARTIAL AGREEMENT IN THE SOCIAL AND PUBLIC HEALTH FIELD) RESOLUTION AP (82) 2 ON THE CLASSIFICATION OF MEDICINES WHICH ARE OBTAINABLE ONLY ON MEDICAL PRESCRIPTION (Adopted by the Committee of Ministers on 2 June 1982 at the 348th meeting of the Ministers' Deputies and superseding Resolution AP (77) 1) AND APPENDIX containing the list of medicines adopted by the Public Health Committee (Partial Agreement) updated to 31 October 1982 RESOLUTION AP (82) 2 ON THE CLASSIFICATION OF MEDICINES WHICH ARE OBTAINABLE ONLY ON MEDICAL PRESCRIPTION 1 (Adopted by the Committee of Ministers on 2 June 1982 at the 348th meeting of the Ministers' Deputies) The Representatives on the Committee of Ministers of Belgium, France, the Federal Republic of Germany, Italy, Luxembourg, the Netherlands, the United Kingdom of Great Britain and Northern Ireland, these states being parties to the Partial Agreement in the social and public health field, and the Representatives of Austria, Denmark, Ireland and Switzerland, states which have participated in the public health activities carried out within the above-mentioned Partial Agreement since 1 October 1974, 2 April 1968, 23 September 1969 and 5 May 1964, respectively, Considering that, under the terms of its Statute, the aim of the Council of Europe is to achieve a greater unity between its Members for the purpose of safeguarding and realising the ideals and principles which are their common heritage and facilitating their economic and social progress; Having regard to the
    [Show full text]
  • Harmonized Tariff Schedule of the United States (2004) -- Supplement 1 Annotated for Statistical Reporting Purposes
    Harmonized Tariff Schedule of the United States (2004) -- Supplement 1 Annotated for Statistical Reporting Purposes PHARMACEUTICAL APPENDIX TO THE HARMONIZED TARIFF SCHEDULE Harmonized Tariff Schedule of the United States (2004) -- Supplement 1 Annotated for Statistical Reporting Purposes PHARMACEUTICAL APPENDIX TO THE TARIFF SCHEDULE 2 Table 1. This table enumerates products described by International Non-proprietary Names (INN) which shall be entered free of duty under general note 13 to the tariff schedule. The Chemical Abstracts Service (CAS) registry numbers also set forth in this table are included to assist in the identification of the products concerned. For purposes of the tariff schedule, any references to a product enumerated in this table includes such product by whatever name known. Product CAS No. Product CAS No. ABACAVIR 136470-78-5 ACEXAMIC ACID 57-08-9 ABAFUNGIN 129639-79-8 ACICLOVIR 59277-89-3 ABAMECTIN 65195-55-3 ACIFRAN 72420-38-3 ABANOQUIL 90402-40-7 ACIPIMOX 51037-30-0 ABARELIX 183552-38-7 ACITAZANOLAST 114607-46-4 ABCIXIMAB 143653-53-6 ACITEMATE 101197-99-3 ABECARNIL 111841-85-1 ACITRETIN 55079-83-9 ABIRATERONE 154229-19-3 ACIVICIN 42228-92-2 ABITESARTAN 137882-98-5 ACLANTATE 39633-62-0 ABLUKAST 96566-25-5 ACLARUBICIN 57576-44-0 ABUNIDAZOLE 91017-58-2 ACLATONIUM NAPADISILATE 55077-30-0 ACADESINE 2627-69-2 ACODAZOLE 79152-85-5 ACAMPROSATE 77337-76-9 ACONIAZIDE 13410-86-1 ACAPRAZINE 55485-20-6 ACOXATRINE 748-44-7 ACARBOSE 56180-94-0 ACREOZAST 123548-56-1 ACEBROCHOL 514-50-1 ACRIDOREX 47487-22-9 ACEBURIC ACID 26976-72-7
    [Show full text]
  • Chemical Structure-Related Drug-Like Criteria of Global Approved Drugs
    Molecules 2016, 21, 75; doi:10.3390/molecules21010075 S1 of S110 Supplementary Materials: Chemical Structure-Related Drug-Like Criteria of Global Approved Drugs Fei Mao 1, Wei Ni 1, Xiang Xu 1, Hui Wang 1, Jing Wang 1, Min Ji 1 and Jian Li * Table S1. Common names, indications, CAS Registry Numbers and molecular formulas of 6891 approved drugs. Common Name Indication CAS Number Oral Molecular Formula Abacavir Antiviral 136470-78-5 Y C14H18N6O Abafungin Antifungal 129639-79-8 C21H22N4OS Abamectin Component B1a Anthelminithic 65195-55-3 C48H72O14 Abamectin Component B1b Anthelminithic 65195-56-4 C47H70O14 Abanoquil Adrenergic 90402-40-7 C22H25N3O4 Abaperidone Antipsychotic 183849-43-6 C25H25FN2O5 Abecarnil Anxiolytic 111841-85-1 Y C24H24N2O4 Abiraterone Antineoplastic 154229-19-3 Y C24H31NO Abitesartan Antihypertensive 137882-98-5 C26H31N5O3 Ablukast Bronchodilator 96566-25-5 C28H34O8 Abunidazole Antifungal 91017-58-2 C15H19N3O4 Acadesine Cardiotonic 2627-69-2 Y C9H14N4O5 Acamprosate Alcohol Deterrant 77337-76-9 Y C5H11NO4S Acaprazine Nootropic 55485-20-6 Y C15H21Cl2N3O Acarbose Antidiabetic 56180-94-0 Y C25H43NO18 Acebrochol Steroid 514-50-1 C29H48Br2O2 Acebutolol Antihypertensive 37517-30-9 Y C18H28N2O4 Acecainide Antiarrhythmic 32795-44-1 Y C15H23N3O2 Acecarbromal Sedative 77-66-7 Y C9H15BrN2O3 Aceclidine Cholinergic 827-61-2 C9H15NO2 Aceclofenac Antiinflammatory 89796-99-6 Y C16H13Cl2NO4 Acedapsone Antibiotic 77-46-3 C16H16N2O4S Acediasulfone Sodium Antibiotic 80-03-5 C14H14N2O4S Acedoben Nootropic 556-08-1 C9H9NO3 Acefluranol Steroid
    [Show full text]
  • FAST TOXICOLOGICAL SCREENING KIT by LC-MS/MS – Code SC9005B
    FAST TOXICOLOGICAL SCREENING KIT BY LC-MS/MS – Code SC9005B The kit for the toxicological-forensic analysis is a screening method to analyze hundreds of compounds in positive and negative mode, in plasma and blood. It is possible to determine the following molecµles: POSITIVE MODE: Amitrole Alypin Bamifylline 17 -alpha -Methyltestosterone Amantadine Bamipin 2-Amino -5-chlorobenzophenone Ambroxol Beclamide 2-Amino -5-nitrobenzophenone Ambucetamide Beclometasone dipropionate 2-Hydroxyethylflurazepam Amezinium Befunolol 3,4 -Methylenedioxyamphetamine Amidopyrin Bendiocarb 3,4 -Methylenedioxyethylamphetamine Amidotrizoic Acid Benfluorex 3,4 -Methylenedioxymethamphet amine Amiloride Benodanil 3,5 -Diiodotyrosine Aminodantrolene Benperidole 4-Benzamidosalicyclic acid Aminoglutethimide Benproperine 6-Mercaptourine Aminophenazone Bens µl tap 6-O-Monoacetylmorphine Aminopromazine Bentiromide 7-Aminoclonazepam Aminorex Benzatropine 7-Aminodesmethylflunitrazepam Amiodarone Benzocaine 7-Aminoflunitrazepam Amiphenazole Benzoct amine 7-Aminonitrazepam Amis µl pride Benzododecinium 9-Hydroxyrisperidone Amitriptylin Benzoylecgonine cebutolol Amlodipine Benzthiazuron Aceclidine Ammoidin Berberine Aceclofenac Amorolfine Betamethasone 21 -phosphate Acemetacin Amoxicillin Betaxolol Acep romazine Amphetamine Bevonium Aceprometazine Amrinone Bezafibrate Acetiamin Antazoline Biperiden Acetylaminonitroprophoxybenzene Apalcillin Bisoprolol Aciclovir Apomorphine Bornaprine Actinoquinol Apophedrin Brodifacoum Adenine Apraclonidin Bromacil Adrenalone Aprinidine
    [Show full text]